Mitolyn is a Harvard-research-based optimal weight loss aid that claims to support metabolism naturally. The creators of this ...

Drinking coffee isn't enough to lose weight, but studies have underlined its supportive properties in weight management. A ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame ...

A team of scientists has shown that intermittent fasting (reducing the number of hours of intake and extending the hours of ...

P, bestselling author of Keto Flex, recently joined Gayle Guyardo, host of the globally syndicated health and wellness show Bloom, to discuss the ...

"Alison was the preeminent scholar on adolescent obesity and eating disorders,” said Kerri Boutelle, a pediatrics professor ...

Whatever your motivation is to lose weight most people look at popular diets to do so. But some diets never work ...

A preliminary study on popular weight loss drugs finds participants shed more weight on Zepbound than on Novo Nordisk’s Wegovy, Zepbound maker Eli Lilly said.

People prescribed semaglutide, sold as Ozempic and Wegovy, to lose weight, may have a higher risk of developing a serious but rare eye condition, a study suggests. Analysing 17,000 patients over ...

Quelch, John A., and Heather Beckham. "Metabical: Positioning and Communications Strategy for a New Weight Loss Drug (Brief Case)." Harvard Business School Teaching Note 104-241, July 2010.

Quelch, John A., and Heather Beckham. "Metabical: Pricing, Packaging, and Demand Forecasting Recommendations for a New Weight Loss Drug (Brief Case)." Harvard Business School Teaching Note 104-184, ...